ATEC Spine has commercially launched Valence, a fully integrated robotic and navigation system for spine surgery.¹ For us at Interventional Systems, this is a milestone worth acknowledging: Valence is built on the miniature robotic technology we developed, which found its way into the spine market through Fusion Robotics and eventually into ATEC’s hands via their acquisition of Accelus in 2023.²
The platform is designed around ATEC’s lateral surgical approach, addressing two of the more persistent challenges in that workflow: fluoroscopy exposure during the procedure and the complexity of surgical corridor creation during lateral access.
System Overview
Valence uses optical instrument tracking and registration to an intraoperative 3D scan. It supports three workflows: robotic-assisted screw navigation, freehand screw navigation, and freehand disc preparation with interbody navigation. The system is validated for pedicle screw placement from T1 to the ilium and interbody device placement from T12/L1 through L5/S1.
It integrates with ATEC’s SafeOp neuromonitoring via the Delta Dilator for real-time neural awareness during lateral access, and is compatible with existing intraoperative 3D imaging systems, allowing institutions to use capital equipment already in place.
Commercial Rollout
Valence’s price point is in the half-million-dollar range, roughly half the cost of large-format competing platforms. The system requires no contracted utilization volumes from hospitals and is designed to be viable across a range of settings, including community hospitals and ambulatory surgery centers. ATEC has initiated a controlled commercial release throughout 2026, with a stated focus on institutions coming to the end of existing navigation contracts.³
ATEC reported $764 million in revenue for 2025, up 25% year over year, and has identified Valence as a central part of its technology strategy going forward.¹
Bringing Miniature Robotics to More Fields
At Interventional Systems, we want to make robotic precision available for every minimally invasive procedure, across all specialties and clinical settings. Valence in Spine is one expression of that. Closer to home, our own Micromate platform is doing the same in interventional radiology and oncology, enabling precise, image-guided percutaneous procedures from head to toe. Our spin-off venture, LARC Robotics, is applying the same approach to urology, specifically to simplify renal access in percutaneous nephrolithotomy. And last year, we announced a partnership with Shoulder Innovations to bring a micro-robotic solution to shoulder arthroplasty.
Different specialties, different workflows, but the same underlying conviction that a well-designed miniature robot should fit into a procedure, not the other way around.
¹ ATEC Spine —Q4 & Full Year 2025 Financial Results, February 24, 2026
² ATEC Spine —ATEC Acquires Navigation-Enabled Robotics Platform, press release, April 2023
³ ATEC Spine — Barclays 28th Annual Global Healthcare Conference, March 11
